Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology
Reference78 articles.
1. Reiman EM, Langbaum JB, Tariot PN, Lopera F, Bateman RJ, Morris JC et al. CAP—advancing the evaluation of preclinical Alzheimer disease treatments. Nat Rev 2016; 12: 56–61.
2. Sperling RA, Amariglio RE, Marshall GA, Rentz DM . Establishing clinical relevance in preclinical alzheimer's disease. J Prev Alzheimers Dis 2015; 2: 85–87.
3. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 280–292.
4. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol 2014; 13: 614–629.
5. Eikelenboom P, Veerhuis R, van Exel E, Hoozemans JJ, Rozemuller AJ, van Gool WA . The early involvement of the innate immunity in the pathogenesis of late-onsetAlzheimer's disease: neuropathological, epidemiological and genetic evidence. Curr Alzheimer Res 2011; 8: 142–150.
Cited by
107 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献